Tylenol, Listerine and Band-Aid will soon have a new home, as parent company Johnson & Johnson intends to break itself up into two public companies by shedding its consumer products segment.
Top line
The New Jersey-based healthcare giant will create a new company out of its household goods division, which includes Benadryl, Neutrogena and Aveeno, while holding on to its business selling drugs and medical devices. The new enterprise has yet to be named.
The split is expected to occur in 18 to 24 months.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in